| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |